Patients with ultra-rare bone marrow disease set to benefit from ÂŁ1.15m grant from LifeArc and The Aplastic Anaemia Trust

A research grant to investigate the potential of a novel type of “personalised cellular therapy” to reverse the ultra-rare condition, aplastic anaemia

MRC Technology and Yabao Pharmaceuticals Announce Exclusive Partnership in China to Develop Novel Therapeutics for Parkinson’s Disease

New partnership with Yabao Pharmaceutical Co, Inc. to discover, develop and commercialise innovative compounds targeting a specific kinase involved in neurodegeneration, with the aim of developing novel therapeutics for the treatment of Parkinson’s disease.